MDGL – Madrigal Pharmaceuticals Inc
MDGL
$432.60Name : Madrigal Pharmaceuticals, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $10,049,107,968.00
EPSttm : -5.85
Madrigal Pharmaceuticals, Inc.
$432.60
MDGL — Price & Float Short
—— Fair value
★ EPS beat
★ EPS miss
—— Target Price
Float Short %
Float Short %
10.13
Margin Of Safety %
Put/Call OI Ratio
0.44
EPS Next Q Diff
-2.22
EPS Last/This Y
10.85
EPS This/Next Y
11.63
Price
432.31
Target Price
690.44
Analyst Recom
1.19
Performance Q
-19.32
Upside
-148.4%
Beta
-0.99
Ticker: MDGL
22 items
«
‹
of 1
›
»
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-10-12 | MDGL | 467.01 | 0.42 | 0.18 | 14345 |
| 2026-10-13 | MDGL | 452.2 | 0.41 | 1.80 | 14557 |
| 2026-10-14 | MDGL | 459.75 | 0.42 | 0.42 | 14824 |
| 2026-10-15 | MDGL | 459.83 | 0.42 | 0.40 | 15141 |
| 2026-10-16 | MDGL | 449.35 | 0.41 | 0.78 | 15141 |
| 2026-10-19 | MDGL | 447 | 0.47 | 0.14 | 11608 |
| 2026-10-20 | MDGL | 467.7 | 0.47 | 0.34 | 11737 |
| 2026-10-21 | MDGL | 458.12 | 0.46 | 0.14 | 11972 |
| 2026-10-22 | MDGL | 453.28 | 0.46 | 9.99 | 12007 |
| 2026-10-23 | MDGL | 433.83 | 0.47 | 0.19 | 12129 |
| 2026-10-26 | MDGL | 437.42 | 0.47 | 1.44 | 12195 |
| 2026-10-27 | MDGL | 440.75 | 0.47 | 1.42 | 12389 |
| 2026-10-28 | MDGL | 431.42 | 0.47 | 0.17 | 12387 |
| 2026-10-29 | MDGL | 431.59 | 0.47 | 3.17 | 12533 |
| 2026-10-30 | MDGL | 430.17 | 0.47 | 0.04 | 12583 |
| 2026-11-02 | MDGL | 430.83 | 0.47 | 2.90 | 12629 |
| 2026-11-03 | MDGL | 396.06 | 0.54 | 1.21 | 13515 |
| 2026-11-04 | MDGL | 400.73 | 0.46 | 0.22 | 14059 |
| 2026-11-05 | MDGL | 400.77 | 0.44 | 0.11 | 14952 |
| 2026-11-06 | MDGL | 400.24 | 0.43 | 1.30 | 15150 |
| 2026-11-09 | MDGL | 432.83 | 0.44 | 0.68 | 15327 |
| 2026-11-10 | MDGL | 433.6 | 0.44 | 0.96 | 15751 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
22 items
«
‹
Current Page1 of 1
›
»
22 items
«
‹
of 1
›
»
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-10-12 | MDGL | 466.75 | 78.1 | - | -6.49 |
| 2026-10-13 | MDGL | 452.12 | 78.1 | - | -6.49 |
| 2026-10-14 | MDGL | 459.90 | 78.1 | - | -6.49 |
| 2026-10-15 | MDGL | 459.45 | 78.1 | - | -6.49 |
| 2026-10-16 | MDGL | 449.75 | 78.1 | - | -6.49 |
| 2026-10-19 | MDGL | 447.13 | 78.1 | - | -6.49 |
| 2026-10-20 | MDGL | 447.13 | 78.1 | - | -6.49 |
| 2026-10-21 | MDGL | 467.41 | 78.1 | - | -6.49 |
| 2026-10-22 | MDGL | 453.25 | 78.1 | - | -6.49 |
| 2026-10-23 | MDGL | 433.70 | 78.1 | - | -6.49 |
| 2026-10-26 | MDGL | 437.42 | 78.1 | - | -6.49 |
| 2026-10-27 | MDGL | 440.76 | 78.1 | - | -6.49 |
| 2026-10-28 | MDGL | 431.22 | 78.1 | - | -6.49 |
| 2026-10-29 | MDGL | 431.28 | 78.1 | - | -6.49 |
| 2026-10-30 | MDGL | 430.16 | 78.1 | - | -6.49 |
| 2026-11-02 | MDGL | 430.84 | 78.1 | - | -6.49 |
| 2026-11-03 | MDGL | 396.06 | 78.1 | - | -6.49 |
| 2026-11-04 | MDGL | 400.79 | 83.6 | - | -6.49 |
| 2026-11-05 | MDGL | 400.54 | 83.6 | - | -6.49 |
| 2026-11-06 | MDGL | 399.83 | 83.6 | - | -6.49 |
| 2026-11-09 | MDGL | 432.81 | 83.6 | - | -6.49 |
| 2026-11-10 | MDGL | 432.31 | 146.3 | - | -2.00 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
22 items
«
‹
Current Page1 of 1
›
»
21 items
«
‹
of 1
›
»
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-10-12 | MDGL | -1.40 | -1.80 | 11.13 |
| 2026-10-13 | MDGL | -1.41 | -1.80 | 11.13 |
| 2026-10-14 | MDGL | -1.41 | -1.80 | 11.13 |
| 2026-10-15 | MDGL | -1.41 | -1.80 | 11.13 |
| 2026-10-16 | MDGL | -1.41 | -1.80 | 11.13 |
| 2026-10-19 | MDGL | -1.41 | -1.76 | 11.13 |
| 2026-10-20 | MDGL | -1.41 | -1.76 | 11.13 |
| 2026-10-21 | MDGL | -1.41 | -1.76 | 11.13 |
| 2026-10-22 | MDGL | -1.41 | -1.76 | 11.13 |
| 2026-10-23 | MDGL | -1.41 | -1.76 | 11.13 |
| 2026-10-26 | MDGL | -1.41 | -2.74 | 11.13 |
| 2026-10-27 | MDGL | -1.41 | -2.74 | 10.19 |
| 2026-10-28 | MDGL | -1.41 | -2.74 | 10.19 |
| 2026-10-29 | MDGL | -1.41 | -2.74 | 10.19 |
| 2026-10-30 | MDGL | -1.41 | -2.74 | 10.19 |
| 2026-11-02 | MDGL | -1.41 | -2.75 | 10.19 |
| 2026-11-03 | MDGL | -1.41 | -2.75 | 10.19 |
| 2026-11-05 | MDGL | -1.41 | -2.75 | 10.19 |
| 2026-11-06 | MDGL | -1.40 | -2.75 | 10.19 |
| 2026-11-09 | MDGL | 4.55 | -2.62 | 10.13 |
| 2026-11-10 | MDGL | 4.55 | -2.62 | 10.13 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
21 items
«
‹
Current Page1 of 1
›
»
Last Quarter Act. EPS
1.83
Avg. EPS Est. Current Quarter
1.19
Avg. EPS Est. Next Quarter
-0.39
Insider Transactions
4.55
Institutional Transactions
-2.62
Beta
-0.99
Average Sales Estimate Current Quarter
477
Average Sales Estimate Next Quarter
460
Fair Value
Quality Score
49
Growth Score
28
Sentiment Score
85
Actual DrawDown %
29.7
Max Drawdown 5-Year %
-61.4
Target Price
690.44
P/E
Forward P/E
60.34
PEG
P/S
7.04
P/B
16.02
P/Free Cash Flow
EPS
-5.98
Average EPS Est. Cur. Y
-2
EPS Next Y. (Est.)
9.62
Target Price Estimates Raised
3
Target Price Estimates Lowered
Profit Margin
-10.89
Relative Volume
1.3
Return on Equity vs Sector %
-51.1
Return on Equity vs Industry %
-31.4
EPS 1 7Days Diff
4.5
EPS 1 30Days Diff
4.49
EBIT Estimation
◆
MDGL
Healthcare
$432.60
📉
N/A
Swing / Pullback
Buy the dip on strong trends
WEAK
Trend
0/20
Pullback
11/25
Volume
0/15
Valuation
15/20
TP/AR
3/10
Options
5/10
RSI
44.2
Range 1M
62.5%
Sup Dist
5.2%
🚀
N/A
Momentum Growth
Ride accelerating trends
WEAK
Momentum
0/25
Growth
29/30
Estimates
3/20
Inst/Vol
2/15
Options
6/10
EPS Yr
84.3%
EPS NY
456%
52W%
30.9%
💎
N/A
Long-Term Value
Quality companies, undervalued
WEAK
🟡 HOLD
+1.2% upside
Quality
6/30
Valuation
2/30
Growth
22/25
Stability
6/10
LT Trend
0/5
Upside
+1.2%
Quality
49
Click a card to see score breakdown
Full Analysis →
MDGL — P/E HistoricalBiotechnology
Sector: Healthcare
Industry: Biotechnology
Employees: 915
Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company was founded in 2016 and is headquartered in West Conshohocken, Pennsylvania.
MDGL
Latest News
—
Caricamento notizie per MDGL…
stock quote shares MDGL – Madrigal Pharmaceuticals Inc Stock Price stock today
news today MDGL – Madrigal Pharmaceuticals Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch MDGL – Madrigal Pharmaceuticals Inc yahoo finance google finance
stock history MDGL – Madrigal Pharmaceuticals Inc invest stock market
stock prices MDGL premarket after hours
ticker MDGL fair value insiders trading